"We're excited to achieve the first milestone of our collaboration with Merck and continue our work to improve biologic ...
The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...
(Bloomberg) -- Merck KGaA posted earnings that topped estimates as its ... the mid-point and sales around the lower half of ...
The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...
Merck KGaA (MRCG.DE), opens new tab on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by ...
On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...
Hosted on MSN9h
Health Care Roundup: Market TalkCurrently, it is too early to tell if this trend will continue, causing the company to temper its FY and 4Q outlooks out of caution, Anevski says. Shares fall 19%. ([email protected]) 0612 ET – ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback